In cartilage regeneration, stem cells have multiple differentiation and self-replicating abilities, making them an ideal choice for use as seed cells. Stem cell-based therapy has become a key focus in functional replacement of cartilage regeneration. Stem cell therapy, or regenerative medicine, promotes the repair response of diseased, dysfunctional, or injured tissue using stem cells or their derivatives.
Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2448
Increasing preference for or increasing number of minimally invasive surgeries worldwide is expected to boost the growth of the global stem cell cartilage regeneration market. Minimally invasive procedures have the potential to delay or avoid knee replacement surgery, repair joint cartilage, halt progression of arthritic damage, and decrease inflammation.
Moreover, increase in demand for efficient and promising treatment (such as stem cell therapy) due to high prevalence of osteoarthritis across the globe is expected to augment growth of the global stem cell cartilage regeneration market. For instance, according to the data published in November 2017 by Arthritis Foundation, Arthritis was one of the leading causes of disability in the United States. More than 53 million individuals around the world suffering from arthritis, and the number is expected to reach around 78.4 million by 2040.
By Stem Cell Type:
- Hematopoietic Stem Cells
- Pluripotent Stem Cells
- Mesenchymal Stem Cells
- Osteochondral Transplant
- Autologous Chondrocyte Implantation
By End User:
- Hospitals & Clinics
- Ambulatory Surgical Centers
- North America
- Latin America
- Asia Pacific
- Middle East
Among regions, North America is expected to witness robust growth in the global stem cell cartilage regeneration market owing to increasing prevalence of degenerative diseases, growing geriatric population, and the presence of major key players in this region. For instance, players in the market, such as Osiris Therapeutics and Vericel Corp., are adopting various strategies such as product approvals and product launch. Moreover, as per the Centers for Disease Control and Prevention (CDC), each year (between 2013 and 2015), around 22.7% of US population (more than 54 million American adults) suffered from some form of arthritis such as lupus, gout, fibromyalgia, or rheumatoid arthritis.
Get PDF Sample Copy of Report (Including Full TOC, List of Tables & Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-sample/2448
Furthermore, Asia Pacific is also expected to witness significant growth in the global stem cell cartilage regeneration market due to the increasing number of stem cell cartilage regeneration procedures in this region. In India, hospitals/clinics, such as Trauma & Orthopaedic Speciality Hospital (TOSH) and Apollo, are conducting stem cell cartilage regeneration procedures.
Major players active in the global stem cell cartilage regeneration market are BioTissue SA, Osiris Therapeutics, Inc., Vericel Corporation, Merck KGaA, CellGenix GmbH, Xintela AB, Orthocell Ltd., and Theracell Advanced Biotechnology Ltd., among others.
Buy This Report with Flat USD 2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/2448
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Stem Cell Cartilage Regeneration Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Stem Cell Cartilage Regeneration Industry Impact
Chapter 2 Global Stem Cell Cartilage Regeneration Competition by Types, Applications, and Top Regions and Countries
2.1 Global Stem Cell Cartilage Regeneration (Volume and Value) by Type
2.3 Global Stem Cell Cartilage Regeneration (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Stem Cell Cartilage Regeneration Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Stem Cell Cartilage Regeneration Market Analysis
Chapter 6 East Asia Stem Cell Cartilage Regeneration Market Analysis
Chapter 7 Europe Stem Cell Cartilage Regeneration Market Analysis
Chapter 8 South Asia Stem Cell Cartilage Regeneration Market Analysis
Chapter 9 Southeast Asia Stem Cell Cartilage Regeneration Market Analysis
Chapter 10 Middle East Stem Cell Cartilage Regeneration Market Analysis
Chapter 11 Africa Stem Cell Cartilage Regeneration Market Analysis
Chapter 12 Oceania Stem Cell Cartilage Regeneration Market Analysis
Chapter 13 South America Stem Cell Cartilage Regeneration Market Analysis
Chapter 14 Company Profiles and Key Figures in Stem Cell Cartilage Regeneration Business
Chapter 15 Global Stem Cell Cartilage Regeneration Market Forecast (2022-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027